Top Markets
Coin of the day
Sai Life Sciences Limited Sai Life Sciences Limited

Sai Life Sciences Limited

SAILIFE
Rank in Stocks #4671
Sai Life Sciences Limited operates as a contract research, development, and... Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India.
Share Price
$16.12
Market Cap
$3.42B
Change (1 day)
0.38%
Change (1 year)
64.10%
Country
IN
Trade Sai Life Sciences Limited (SAILIFE)

Category

P/E ratio for Sai Life Sciences Limited (SAILIFE)
P/E ratio as of 2026 TTM: 0
According to Sai Life Sciences Limited latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Sai Life Sciences Limited from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
31.59 -
US
35.83 -
US
- -
CN
-227.89 -
US
29.77 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.